{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7478,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "thesis_headline",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/23",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-23",
      "loopMatches": [
        {
          "to": 24,
          "from": 23,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "2d1fd31a-1e17-421e-99fe-ab78f0c7a3f8",
          "evidence": "Slides 23-24 present the investment thesis and compelling opportunity",
          "position": 1,
          "objective": "Why is now the right time to invest in NeuroBo Pharmaceuticals?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/24",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-24",
      "loopMatches": [
        {
          "to": 24,
          "from": 23,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "2d1fd31a-1e17-421e-99fe-ab78f0c7a3f8",
          "evidence": "Slides 23-24 present the investment thesis and compelling opportunity",
          "position": 1,
          "objective": "Why is now the right time to invest in NeuroBo Pharmaceuticals?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-86c0-778c-b811-8ed1a345f3e4",
      "docSlug": "3a23784462a131093cb118313f70597a",
      "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides",
      "authorId": "neurobo-pharmaceuticals",
      "authorName": "NeuroBo Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-86c0-778c-b811-8ed1a345f3e4/25",
      "deckHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4",
      "deckAnchorHref": "/decks/019de076-86c0-778c-b811-8ed1a345f3e4#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Features a scientific illustration of a synapse.",
      "imagePath": "https://imgproxy.kitesheet.com/iryd0s10LwWIlQme5gode11fVddR6F-YhSmOX4qJzWw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjAxNzZiNDEwYTcyYTZiMmU2N2FmNWRkMmEyMDc1OC9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/1",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/KoTUF1qeTqrE27F31yd72C61X2BDong-C94ICYAWYfA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjAxNzZiNDEwYTcyYTZiMmU2N2FmNWRkMmEyMDc1OC9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/941_YkXfu9e9VGY7PQUtJ7VdO9qWiyowTPdyBBCSt1U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjAxNzZiNDEwYTcyYTZiMmU2N2FmNWRkMmEyMDc1OC9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/JJhBIB3FFVy4qNZhcr4kc1toyvGDNWmgrCOAUTNlEBg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjAxNzZiNDEwYTcyYTZiMmU2N2FmNWRkMmEyMDc1OC9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/2",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/3",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a standard pharmaceutical pipeline visualization format.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/4",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "Uses a personal narrative (Shay) to humanize the disease progression alongside clinical data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/5",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 5,
          "beatId": "0c6dc7ee-9e73-4f02-a0ba-70360d2eb84a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies ALS as a significant problem, highlighting its debilitating nature and limited treatment options.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 6,
          "from": 5,
          "beatId": "d139c8b0-bfb8-4e22-92c8-f4d01b6477cc",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document agitates the problem by highlighting the limitations and side effects of current ALS treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological mechanism-of-action diagram to illustrate how the two components of PrimeC address specific cellular stressors in ALS.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/6",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 5,
          "beatId": "d139c8b0-bfb8-4e22-92c8-f4d01b6477cc",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document agitates the problem by highlighting the limitations and side effects of current ALS treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a combination of a biological process diagram and a pharmacokinetic line chart to demonstrate drug synergy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/7",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart uses hazard ratio as a metric for efficacy in an iPSC model derived from ALS patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/8",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The chart highlights a 'Synchronized concentration peak' at 5 hours for both PrimeC components.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/9",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes study design parameters (NST002) and key clinical outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/10",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "Includes details on screen failures and misdiagnosis exclusions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/11",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a numbered list format to categorize clinical trial endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/12",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "appendix_methodology",
      "function": "analyze_data",
      "notes": "The slide defines the statistical populations used for the clinical trial results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/13",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "appendix_methodology",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/14",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Shows balanced enrollment across key metrics like age, BMI, and disease severity (ALSFRS-R).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/15",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide highlights clinical trial safety data for PrimeC.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/16",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-16",
      "loopMatches": [
        {
          "to": 17,
          "from": 16,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "eac28707-c928-4f11-b43c-15fe53094ee6",
          "evidence": "The document presents data showing that PrimeC significantly attenuated disease progression by 37% in ALSFRS-R.",
          "position": 1,
          "objective": "How does PrimeC compare to placebo in terms of disease progression?",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.7,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide highlights a 37.4% reduction in disease progression with statistical significance (p=0.03) in the per-protocol population, while noting a 29% reduction in the ITT analysis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/17",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-17",
      "loopMatches": [
        {
          "to": 17,
          "from": 16,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "eac28707-c928-4f11-b43c-15fe53094ee6",
          "evidence": "The document presents data showing that PrimeC significantly attenuated disease progression by 37% in ALSFRS-R.",
          "position": 1,
          "objective": "How does PrimeC compare to placebo in terms of disease progression?",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.7,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide uses a list of icons to anchor the clinical impact of the ALSFRS-R scale.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/18",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-18",
      "loopMatches": [
        {
          "to": 19,
          "from": 18,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b3aafb36-7f5f-45f1-8a8b-bb4f4179cf96",
          "evidence": "The document highlights the significant impact of losing or keeping a single point on the ALSFRS-R scale, emphasizing the importance of effective treatment.",
          "position": 0,
          "objective": "What is the cost of not treating ALS effectively?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart visualizes the reduction in points lost, highlighting a 3.22 point difference (p=0.03).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/19",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-19",
      "loopMatches": [
        {
          "to": 19,
          "from": 18,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b3aafb36-7f5f-45f1-8a8b-bb4f4179cf96",
          "evidence": "The document highlights the significant impact of losing or keeping a single point on the ALSFRS-R scale, emphasizing the importance of effective treatment.",
          "position": 0,
          "objective": "What is the cost of not treating ALS effectively?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "The slide uses a human body diagram to categorize ALS symptoms and bar charts to show the reduction in point loss (slower disease progression) for each category.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/20",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart highlights a 17.2% attenuation in the decline of SVC score for the PrimeC group compared to placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/21",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide highlights the PARADIGM trial's research pillars, including proteomics, microRNA, exosomes, and neurofilaments, in partnership with institutions like MGH and Harvard.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/22",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "comparison_table",
      "function": "cite_precedent",
      "notes": "The slide uses a 'Case Study' to validate the company's own strategy of combination therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/23",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/24",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-24",
      "loopMatches": [
        {
          "to": 25,
          "from": 24,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "e681d414-7700-4a5b-99a5-b22bec923cbe",
          "evidence": "The document mentions the potential for PrimeC in Alzheimer's disease, highlighting its broad therapeutic potential.",
          "position": 2,
          "objective": "What is the potential for PrimeC in other neurodegenerative diseases?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 24,
          "from": 6,
          "beatId": "34d973c9-414c-4e7d-9b2b-216172775550",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents PrimeC as a solution, highlighting its unique formulation, preclinical efficacy, and promising clinical trial results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide presents clinical biomarker data (Aβ40, Aβ42, Tau, pTau, PgJ2) comparing control vs AD groups, analyzed via Mann-Whitney U test.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/25",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-25",
      "loopMatches": [
        {
          "to": 25,
          "from": 24,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "e681d414-7700-4a5b-99a5-b22bec923cbe",
          "evidence": "The document mentions the potential for PrimeC in Alzheimer's disease, highlighting its broad therapeutic potential.",
          "position": 2,
          "objective": "What is the potential for PrimeC in other neurodegenerative diseases?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines the methodology for a Phase 2 clinical trial for Alzheimer's Disease (AD).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/26",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
      "docSlug": "560176b410a72a6b2e67af5dd2a20758",
      "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
      "authorId": "neurosense-therapeutics",
      "authorName": "NeuroSense Therapeutics",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a grid layout to present headshots and credentials, with institutional logos aligned below each relevant member.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/27",
      "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
      "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}